Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?Zacks Investment Research • 06/30/26
Grab These 4 Stocks With Solid Net Profit Margins to Maximize ReturnsZacks Investment Research • 06/29/26
Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In ViewInvestors Business Daily • 06/23/26
Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep goingZacks Investment Research • 06/19/26
Kiniksa Pharmaceuticals International, plc (KNSA) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 06/16/26
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/10/26
Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher TodayThe Motley Fool • 04/28/26
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call TranscriptSeeking Alpha • 04/28/26
Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 04/28/26
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio ExecutionGlobeNewsWire • 04/28/26
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026GlobeNewsWire • 04/23/26
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent PericarditisGlobeNewsWire • 04/08/26
Stock Of The Day In Buy Zone, Leads Industry Despite Supersmall MarketInvestors Business Daily • 04/06/26
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care ConferenceGlobeNewsWire • 02/25/26
Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call TranscriptSeeking Alpha • 02/24/26
Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings EstimatesZacks Investment Research • 02/24/26
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio ExecutionGlobeNewsWire • 02/24/26
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026GlobeNewsWire • 02/19/26